All News Xiamen Amoytop Biotech Co., Ltd.

Equities

688278

CNE100003RT3

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 31/05/2024 am IST			5-day change	1st Jan Change
54.65 ^CNY	+0.94%		+0.09%	+4.39%

22/04	Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
18/03	China Stocks Advance Over Positive Economic Data; Amoytop Biotech Rises 6%	MT

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	22/04	CI
China Stocks Advance Over Positive Economic Data; Amoytop Biotech Rises 6%	18/03	MT
Xiamen Amoytop Biotech Gets Nod to Market Hepatitis Drug; Shares Up 4%	18/03	MT
Amoytop Biotech's 2023 Profit Jumps 93%	26/02	MT
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	23/02	CI
'Hawkish' China military squeeze on Taiwan likely after election	03/01	RE
Taiwan not seeing signs of large-scale Chinese military activity pre-election	26/12	RE
Taiwan to 'handle' spate of Chinese balloons based on threat level	20/12	RE
Taiwan reports more suspected Chinese weather balloons crossing Taiwan Strait	18/12	RE
Xiamen Amoytop Biotech Co., Ltd.(SHSE:688278) added to Shanghai Stock Exchange Health Care Sector Index	11/12	CI
Amoytop Biotech Signs Exclusive License Deal for Liver Disease Drug With Alphamab Unit	07/12	MT
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	19/23/19	CI
Taiwan raises concerns about situation 'getting out of hand' with China drills	23/23/23	RE
Xiamen Amoytop Biotech Co., Ltd.(XSSC:688278) added to S&P Global BMI Index	18/23/18	CI
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	17/23/17	CI
Amoytop Biotech Signs Exclusive Commercialization Deal With Fosun Unit	01/23/01	MT
Sector Update: Health Care Stocks Edge Higher Premarket Monday	15/23/15	MT
Top Premarket Gainers	15/23/15	MT
Aligos Therapeutics to Collaborate with Xiamen Amoytop Biotech on Liver Disease Treatments; Aligos Shares Jump	15/23/15	MT
Huihe Biotechnology Co., Ltd. announced that it has received CNY 100 million in funding from Shanghai Prosperico Ventures Co., Ltd., Shenzhen Capital Group Co., Ltd., Jolmo Investment Management Co., Ltd., Xiamen Amoytop Biotech Co., Ltd., Hangzhou Tailong Venture Capital Partnership Enterprise (L.P.)	15/23/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Xiamen Amoytop Biotech Co., Ltd.

Equities

688278

CNE100003RT3

All News

Filters